Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Warfarin in the treatment of antiphospholipid syndrome].

Terapevticheskii arkhiv - 1 Jan 2007

Reshetniak T M, Kondrat'eva L V, Patrusheva N L, Patrushev L I

Abstract excerpt

AIM: To assess efficacy and safety of warfarin therapy and its combination with low-dose acetylsalicylic acid (ASA) in antiphospholipid syndrome (APS). MATERIAL AND METHODS: The trial enrolled 60 APS patients. They were divided into two groups: group 1 (n = 39) on antithrombotic therapy with warfarin; group 2 (n = 21) on combined therapy with warfarin and ASA. Efficacy of the treatments was assessed by the number...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Thrombosis
Share to Warfarin
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anticoagulants

Share to Antiphospholipid Syndrome

Share to Aspirin

Share to Blood Coagulation

Share to Cerebrovascular Circulation

Source

Identifiers

PMID: 17672075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Warfarin in the treatment of antiphospholipid syndrome].PMID 17672075Read ↗

[Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].Semantic proximity Read ↗

[Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].Semantic proximity Read ↗

[Antiphospholipid syndrome in the structure of hematogenic thrombophilia in young and middle-aged patients with venous thrombosis].Semantic proximity Read ↗

[Genetic predisposition to bleeding during oral anticoagulants treatment].Semantic proximity Read ↗

The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome.Semantic proximity Read ↗

[Monitoring of low-molecular-weight heparins in pregnant women with inherited thrombophilic disorders].Semantic proximity Read ↗

[Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].Semantic proximity Read ↗

LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.Semantic proximity Read ↗

[Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study].Semantic proximity Read ↗

[Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome].Semantic proximity Read ↗

[Clinical value of allele variants of cytochrome CYP2C9 gene for anticoagulation therapy with warfarin].Semantic proximity Read ↗

CYP2C9 and VKORC1 gene polymorphism is inessential for bleeding development under conditions of oral application of anticoagulant acenocoumarol in Russian patients at high risk of thromboembolic complications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.